private equity

Page 28 of 100

empty chairs surround a brightly lit conference stage
Newsletters

What GPs and LPs say to each other behind closed doors

By
July 19, 2024
How to communicate with Gen Z: “Be more vulnerable than you think you need to be”
Newsletters

How to communicate with Gen Z: “Be more vulnerable than you think you need to be”

By
July 18, 2024
Mark Suster, a partner at Upfront Ventures, spoke about A.I. on a panel at Fortune Brainstorm Tech 2024
Finance

Venture firms need to emulate private equity, says Upfront Ventures partner Mark Suster

By
July 17, 2024
Marc Andreessen
Politics

Andreessen Horowitz founders the latest to stake Trump, as tech money piles into his coffers

By Lizette Chapman, Bill Allison and Bloomberg
July 16, 2024
What you need to know about J.D. Vance’s VC career
Newsletters

What you need to know about J.D. Vance’s VC career

By
July 16, 2024
Private credit is growing into a $3.5 trillion industry: Meet 9 execs leading the way
Finance

Private credit is growing into a $3.5 trillion industry: Meet 9 execs leading the way

By
July 16, 2024
A new credit card for NYC millionaires has over 30,000 people on the waitlist
Newsletters

A new credit card for NYC millionaires has over 30,000 people on the waitlist

By
July 15, 2024
AI startups raised $24 billion globally in Q2, but the question remains: Where will value in AI accrue? Here’s one VC’s (slightly) contrarian take.
Newsletters

AI startups raised $24 billion globally in Q2, but the question remains: Where will value in AI accrue? Here’s one VC’s (slightly) contrarian take.

By
July 12, 2024
Exclusive: Armada lands $40 million in funding round led by Microsoft’s M12
Newsletters

Exclusive: Armada lands $40 million in funding round led by Microsoft’s M12

By
July 11, 2024
A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. The company's revenues rose by 38% to DKK 58.73 billion, some 7.8 billion euros. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug.
Newsletters

As more and more weight-loss startups prescribe Ozempic and Wegovy, doctors say they’re making unproven claims

By Jessica Mathews and Alena Botros
July 10, 2024
Goldman Sachs’ CEO was seen as a dead man walking. A year later, the “David Solomon” era is being hailed as a success
Finance

Goldman Sachs’ CEO was seen as a dead man walking. A year later, the “David Solomon” era is being hailed as a success

By
July 9, 2024
Exclusive: Canoe Intelligence raises $36 million for Series C led by Goldman Sachs
Newsletters

Exclusive: Canoe Intelligence raises $36 million for Series C led by Goldman Sachs

By
July 9, 2024
How whaling ventures in the 1800s shaped venture capital as we know it
Newsletters

How whaling ventures in the 1800s shaped venture capital as we know it

By
July 8, 2024
Fintech is likely to face increased scrutiny after Evolve hack
Newsletters

Fintech is likely to face increased scrutiny after Evolve hack

By
July 5, 2024
Why Universal Hydrogen folded—and why the company’s mission will live on
Newsletters

Why Universal Hydrogen folded—and why the company’s mission will live on

By
July 3, 2024

Most Popular